A. Pluen, Y. Boucher, and S. Ramanujan, Role of tumor-host interactions in interstitial diffusion of macromolecules: cranial versus subcutaneous tumors, Proceedings of the National Academy of Sciences of the United States of America, vol.98, pp.4628-4633, 2001.

B. J. Druker, C. L. Sawyers, and H. Kantarjian, Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome, The New England Journal of Medicine, vol.344, issue.14, pp.1038-1042, 2001.

J. L. Biedler and H. Riehm, Cellular resistance to actinomycin D in Chinese hamster cells in vitro: cross-resistance, radioautographic, and cytogenetic studies, Cancer Research, vol.30, issue.4, pp.1174-1184, 1970.

J. A. Endicott and V. Ling, The biochemistry of P-glycoproteinmediated multidrug resistance, Annual Review of Biochemistry, vol.58, pp.137-171, 1989.

I. Bosch and J. Croop, P-glycoprotein multidrug resistance and cancer, Biochimica et Biophysica Acta, vol.1288, issue.2, pp.37-54, 1996.

S. V. Ambudkar, S. Dey, C. A. Hrycyna, M. Ramachandra, I. Pastan et al., Biochemical, cellular, and pharmacological aspects of the multidrug transporter, Annual Review of Pharmacology and Toxicology, vol.39, pp.361-398, 1999.

S. V. Ambudkar, C. Kimchi-sarfaty, Z. E. Sauna, and M. M. Gottesman, P-glycoprotein: from genomics to mechanism, Oncogene, vol.22, issue.47, pp.7468-7485, 2003.

A. H. Schinkel, The physiological function of drugtransporting P-glycoproteins, Seminars in Cancer Biology, vol.8, issue.3, pp.161-170, 1997.

I. B. Holland and M. A. Blight, ABC-ATPases, adaptable energy generators fuelling transmembrane movement of a variety of molecules in organisms from bacteria to humans, Journal of Molecular Biology, vol.293, issue.2, pp.381-399, 1999.

D. Turk and G. Szakacs, Relevance of multidrug resistance in the age of targeted therapy, Current opinion in Drug Discovery & Development, vol.12, pp.246-252, 2009.

B. J. Trock, F. Leonessa, and R. Clarke, Multidrug resistance in breast cancer: a meta-analysis of MDR1/gp170 expression and its possible functional significance, Journal of the National Cancer Institute, vol.89, issue.13, pp.917-931, 1997.

I. F. Faneyte, P. M. Kristel, M. J. Van-de, and . Vijver, Determining MDR1/P-glycoprotein expression in breast cancer, The International Journal of Cancer, vol.93, pp.114-122, 2001.

W. T. Beck, T. M. Grogan, and C. L. Willman, Methods to detect P-glycoprotein-associated multidrug resistance in patients' tumors: consensus recommendations, Cancer Research, vol.56, issue.13, pp.3010-3020, 1996.

H. J. Broxterman, P. Sonneveld, and N. Feller, Quality control of multidrug resistance assays in adult acute leukemia: correlation between assays for P-glycoprotein expression and activity, Blood, vol.87, issue.11, pp.4809-4816, 1996.

J. Meesungnoen, J. Jay-gerin, and S. Mankhetkorn, Relation between MDR1 mRNA levels, resistance factor, and the efficiency of P-glycoprotein-mediated efflux of pirarubicin in multidrug-resistant K562 sublines, Canadian Journal of Physiology and Pharmacology, vol.80, issue.11, pp.1054-1063, 2002.

J. Pasquier, L. Galas, and C. Boulangé-lecomte, Different modalities of intercellular membrane exchanges mediate cellto-cell P-glycoprotein transfers in MCF-7 breast cancer cells, The Journal of Biological Chemistry, vol.287, issue.10, pp.7374-7387, 2012.

O. Legrand, G. Simonin, J. Y. Perrot, R. Zittoun, and J. P. Marie, Pgp and MRP activities using calcein-AM are prognostic factors in adult acute myeloid leukemia patients, Blood, vol.91, issue.12, pp.4480-4488, 1998.

L. Homolya, Z. Hollo, U. A. Germann, I. Pastan, M. M. Gottesman et al., Fluorescent cellular indicators are extruded by the multidrug resistance protein, The Journal of Biological Chemistry, vol.268, issue.29, pp.21493-21496, 1993.

M. Marin, H. Legros, A. Poret, F. Leboulenger, and F. L. Foll, Cell responses to xenobiotics: comparison of MCF7 multi-drug-and mussel blood cell multi-xenobiotic-defense mechanisms, Marine Environmental Research, vol.58, issue.2-5, pp.209-213, 2004.
URL : https://hal.archives-ouvertes.fr/hal-02314844

J. Pasquier, P. Magal, C. Boulangé-lecomte, G. Webb, and F. L. Foll, Consequences of cell-to-cell P-glycoprotein transfer on acquired multidrug resistance in breast cancer: a cell population dynamics model, Biology Direct, vol.6, issue.5, 2011.
URL : https://hal.archives-ouvertes.fr/hal-01738512

D. G. Altman and J. M. Bland, Comparison of methods of measuring blood pressure, Journal of Epidemiology and Community Health, vol.40, issue.3, pp.274-277, 1986.

C. Maulard, J. Marie, S. Delanian, and M. Housset, Clinical effects on CA 15-3 level of cyclosporin A as a chemosensitiser in chemoresistant metastatic breast cancer, European Journal of Cancer A, vol.29, issue.3, p.480, 1993.